drugset / Trial / NCT01159145

Study to Assess the Pharmacodynamics/Pharmacokinetics After Repeated Dosing of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects

NCT01159145 ↗

Phase 1 Completed 42 enrolled AstraZeneca
RandomizedSingle-groupSingle-blind

Summary

The purpose of this study is to assess the pharmacodynamics (intragastric pH) after repeated oral administration of D961H 10 mg and omeprazole 10 mg in Japanese healthy male subjects who are classified by the genotype of CYP2C19 by the assessment of percentage of time with intragastric pH\>4 during 24 hours after dose on day 5.

Timeline

Start
2010-07
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject D961H Unknown 10 mg Oral
Subject Omeprazole Other / unclassified 10 mg Oral

Indications

No indication recorded.